Aeterna Zentaris Learns of Class Action Lawsuits Filed and Denies Allegations
June 19 2012 - 7:30AM
PR Newswire (US)
QUÉBEC CITY, June 19,
2012 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS)
(TSX: AEZ) (the "Company") today announces that the
Company has learned that two putative class action lawsuits have
been filed against it alleging failures to disclose certain
information under U.S. federal securities laws. The Company is in
the process of reviewing the allegations, believes they are without
merit and stands behind its continuous public disclosure record.
Aeterna Zentaris believes that there is absolutely no basis for the
lawsuits, and the Company intends to defend itself vigorously.
About Aeterna Zentaris
Aeterna Zentaris is an oncology and endocrinology drug
development company currently investigating treatments for various
unmet medical needs. The Company's pipeline encompasses compounds
at all stages of development, from drug discovery through to
marketed products. For more information please visit
www.aezsinc.com.
SOURCE AETERNA ZENTARIS INC.
Copyright 2012 PR Newswire
Aeterna Zentaris (NASDAQ:AEZS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Aeterna Zentaris (NASDAQ:AEZS)
Historical Stock Chart
From Jul 2023 to Jul 2024